Table of Contents

1 Market Overview

1.1 Blood Plasma Derivatives Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Blood Plasma Derivatives Revenue by Type: 2015 VS 2019 VS 2025

1.2.2 Albumin

1.2.3 Factor VIII

1.2.4 Factor IX

1.2.5 Immunoglobulin

1.2.6 Hyperimmune Globulin

1.2.7 Others

1.3 Market Analysis by Application

1.3.1 Overview: Global Blood Plasma Derivatives Revenue by Application: 2015 VS 2019 VS 2025

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Other End Users

1.4 Overview of Global Blood Plasma Derivatives Market

1.4.1 Global Blood Plasma Derivatives Market Status and Outlook (2015-2025)

1.4.2 North America (United States, Canada and Mexico)

1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)

1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.5 South America, Middle East & Africa

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Grifols

2.1.1 Grifols Details

2.1.2 Grifols Major Business and Total Revenue (Financial Highlights) Analysis

2.1.3 Grifols SWOT Analysis

2.1.4 Grifols Product and Services

2.1.5 Grifols Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.2 Octapharma AG

2.2.1 Octapharma AG Details

2.2.2 Octapharma AG Major Business and Total Revenue (Financial Highlights) Analysis

2.2.3 Octapharma AG SWOT Analysis

2.2.4 Octapharma AG Product and Services

2.2.5 Octapharma AG Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.3 Biotest AG

2.3.1 Biotest AG Details

2.3.2 Biotest AG Major Business and Total Revenue (Financial Highlights) Analysis

2.3.3 Biotest AG SWOT Analysis

2.3.4 Biotest AG Product and Services

2.3.5 Biotest AG Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.4 SK Plasma

2.4.1 SK Plasma Details

2.4.2 SK Plasma Major Business and Total Revenue (Financial Highlights) Analysis

2.4.3 SK Plasma SWOT Analysis

2.4.4 SK Plasma Product and Services

2.4.5 SK Plasma Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.5 LFB

2.5.1 LFB Details

2.5.2 LFB Major Business and Total Revenue (Financial Highlights) Analysis

2.5.3 LFB SWOT Analysis

2.5.4 LFB Product and Services

2.5.5 LFB Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.6 Fusion Health Care

2.6.1 Fusion Health Care Details

2.6.2 Fusion Health Care Major Business and Total Revenue (Financial Highlights) Analysis

2.6.3 Fusion Health Care SWOT Analysis

2.6.4 Fusion Health Care Product and Services

2.6.5 Fusion Health Care Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.7 Takeda

2.7.1 Takeda Details

2.7.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis

2.7.3 Takeda SWOT Analysis

2.7.4 Takeda Product and Services

2.7.5 Takeda Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.8 Baxter International

2.8.1 Baxter International Details

2.8.2 Baxter International Major Business and Total Revenue (Financial Highlights) Analysis

2.8.3 Baxter International SWOT Analysis

2.8.4 Baxter International Product and Services

2.8.5 Baxter International Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.9 Green Cross Corporation

2.9.1 Green Cross Corporation Details

2.9.2 Green Cross Corporation Major Business and Total Revenue (Financial Highlights) Analysis

2.9.3 Green Cross Corporation SWOT Analysis

2.9.4 Green Cross Corporation Product and Services

2.9.5 Green Cross Corporation Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.10 CSL Limited

2.10.1 CSL Limited Details

2.10.2 CSL Limited Major Business and Total Revenue (Financial Highlights) Analysis

2.10.3 CSL Limited SWOT Analysis

2.10.4 CSL Limited Product and Services

2.10.5 CSL Limited Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.11 Hualan Biological Engineering

2.11.1 Hualan Biological Engineering Details

2.11.2 Hualan Biological Engineering Major Business and Total Revenue (Financial Highlights) Analysis

2.11.3 Hualan Biological Engineering SWOT Analysis

2.11.4 Hualan Biological Engineering Product and Services

2.11.5 Hualan Biological Engineering Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.12 China Biologic Products

2.12.1 China Biologic Products Details

2.12.2 China Biologic Products Major Business and Total Revenue (Financial Highlights) Analysis

2.12.3 China Biologic Products SWOT Analysis

2.12.4 China Biologic Products Product and Services

2.12.5 China Biologic Products Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.13 Bayer AG

2.13.1 Bayer AG Details

2.13.2 Bayer AG Major Business and Total Revenue (Financial Highlights) Analysis

2.13.3 Bayer AG SWOT Analysis

2.13.4 Bayer AG Product and Services

2.13.5 Bayer AG Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.14 Kedrion Biopharma

2.14.1 Kedrion Biopharma Details

2.14.2 Kedrion Biopharma Major Business and Total Revenue (Financial Highlights) Analysis

2.14.3 Kedrion Biopharma SWOT Analysis

2.14.4 Kedrion Biopharma Product and Services

2.14.5 Kedrion Biopharma Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.15 BDI Pharma

2.15.1 BDI Pharma Details

2.15.2 BDI Pharma Major Business and Total Revenue (Financial Highlights) Analysis

2.15.3 BDI Pharma SWOT Analysis

2.15.4 BDI Pharma Product and Services

2.15.5 BDI Pharma Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

3 Sales, Revenue and Market Share by Manufacturer

3.1 Global Blood Plasma Derivatives Sales and Market Share by Manufacturer (2018-2019)

3.2 Global Blood Plasma Derivatives Revenue and Market Share by Manufacturer (2018-2019)

3.3 Market Concentration Rate

3.3.1 Top 3 Blood Plasma Derivatives Manufacturer Market Share in 2019

3.3.2 Top 6 Blood Plasma Derivatives Manufacturer Market Share in 2019

3.4 Market Competition Trend

4 Global Market Analysis by Regions

4.1 Global Blood Plasma Derivatives Sales, Revenue and Market Share by Regions

4.1.1 Global Blood Plasma Derivatives Sales and Market Share by Regions (2015-2020)

4.1.2 Global Blood Plasma Derivatives Revenue and Market Share by Regions (2015-2020)

4.2 North America Blood Plasma Derivatives Sales and Growth Rate (2015-2020)

4.3 Europe Blood Plasma Derivatives Sales and Growth Rate (2015-2020)

4.4 Asia-Pacific Blood Plasma Derivatives Sales and Growth Rate (2015-2020)

4.5 South America Blood Plasma Derivatives Sales and Growth Rate (2015-2020)

4.6 Middle East and Africa Blood Plasma Derivatives Sales and Growth Rate (2015-2020)

5 North America by Country

5.1 North America Blood Plasma Derivatives Sales, Revenue and Market Share by Country

5.1.1 North America Blood Plasma Derivatives Sales and Market Share by Country (2015-2020)

5.1.2 North America Blood Plasma Derivatives Revenue and Market Share by Country (2015-2020)

5.2 United States Blood Plasma Derivatives Sales and Growth Rate (2015-2020)

5.3 Canada Blood Plasma Derivatives Sales and Growth Rate (2015-2020)

5.4 Mexico Blood Plasma Derivatives Sales and Growth Rate (2015-2020)

6 Europe by Country

6.1 Europe Blood Plasma Derivatives Sales, Revenue and Market Share by Country

6.1.1 Europe Blood Plasma Derivatives Sales and Market Share by Country (2015-2020)

6.1.2 Europe Blood Plasma Derivatives Revenue and Market Share by Country (2015-2020)

6.2 Germany Blood Plasma Derivatives Sales and Growth Rate (2015-2020)

6.3 UK Blood Plasma Derivatives Sales and Growth Rate (2015-2020)

6.4 France Blood Plasma Derivatives Sales and Growth Rate (2015-2020)

6.5 Russia Blood Plasma Derivatives Sales and Growth Rate (2015-2020)

6.6 Italy Blood Plasma Derivatives Sales and Growth Rate (2015-2020)

7 Asia-Pacific by Regions

7.1 Asia-Pacific Blood Plasma Derivatives Sales, Revenue and Market Share by Regions

7.1.1 Asia-Pacific Blood Plasma Derivatives Sales and Market Share by Regions (2015-2020)

7.1.2 Asia-Pacific Blood Plasma Derivatives Revenue and Market Share by Regions (2015-2020)

7.2 China Blood Plasma Derivatives Sales and Growth Rate (2015-2020)

7.3 Japan Blood Plasma Derivatives Sales and Growth Rate (2015-2020)

7.4 Korea Blood Plasma Derivatives Sales and Growth Rate (2015-2020)

7.5 India Blood Plasma Derivatives Sales and Growth Rate (2015-2020)

7.6 Southeast Asia Blood Plasma Derivatives Sales and Growth Rate (2015-2020)

7.7 Australia Blood Plasma Derivatives Sales and Growth Rate (2015-2020)

8 South America by Country

8.1 South America Blood Plasma Derivatives Sales, Revenue and Market Share by Country

8.1.1 South America Blood Plasma Derivatives Sales and Market Share by Country (2015-2020)

8.1.2 South America Blood Plasma Derivatives Revenue and Market Share by Country (2015-2020)

8.2 Brazil Blood Plasma Derivatives Sales and Growth Rate (2015-2020)

8.3 Argentina Blood Plasma Derivatives Sales and Growth Rate (2015-2020)

9 Middle East & Africa by Countries

9.1 Middle East & Africa Blood Plasma Derivatives Sales, Revenue and Market Share by Country

9.1.1 Middle East & Africa Blood Plasma Derivatives Sales and Market Share by Country (2015-2020)

9.1.2 Middle East & Africa Blood Plasma Derivatives Revenue and Market Share by Country (2015-2020)

9.2 Saudi Arabia Blood Plasma Derivatives Sales and Growth Rate (2015-2020)

9.3 Turkey Blood Plasma Derivatives Sales and Growth Rate (2015-2020)

9.4 Egypt Blood Plasma Derivatives Sales and Growth Rate (2015-2020)

9.5 South Africa Blood Plasma Derivatives Sales and Growth Rate (2015-2020)

10 Market Segment by Type

10.1 Global Blood Plasma Derivatives Sales and Market Share by Type (2015-2020)

10.2 Global Blood Plasma Derivatives Revenue and Market Share by Type (2015-2020)

10.3 Global Blood Plasma Derivatives Price by Type (2015-2020)

11 Global Blood Plasma Derivatives Market Segment by Application

11.1 Global Blood Plasma Derivatives Sales Market Share by Application (2015-2020)

11.2 Global Blood Plasma Derivatives Revenue Market Share by Application (2015-2020)

11.3 Global Blood Plasma Derivatives Price by Application (2015-2020)

12 Market Forecast

12.1 Global Blood Plasma Derivatives Sales, Revenue and Growth Rate (2021-2025)

12.2 Blood Plasma Derivatives Market Forecast by Regions (2021-2025)

12.2.1 North America Blood Plasma Derivatives Market Forecast (2021-2025)

12.2.2 Europe Blood Plasma Derivatives Market Forecast (2021-2025)

12.2.3 Asia-Pacific Blood Plasma Derivatives Market Forecast (2021-2025)

12.2.4 South America Blood Plasma Derivatives Market Forecast (2021-2025)

12.2.5 Middle East & Africa Blood Plasma Derivatives Market Forecast (2021-2025)

12.3 Blood Plasma Derivatives Market Forecast by Type (2021-2025)

12.3.1 Global Blood Plasma Derivatives Sales Forecast by Type (2021-2025)

12.3.2 Global Blood Plasma Derivatives Market Share Forecast by Type (2021-2025)

12.4 Blood Plasma Derivatives Market Forecast by Application (2021-2025)

12.4.1 Global Blood Plasma Derivatives Sales Forecast by Application (2021-2025)

12.4.2 Global Blood Plasma Derivatives Market Share Forecast by Application (2021-2025)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

15.3 Disclaimer

15.4 About US

List of Tables

Table 1. Global Blood Plasma Derivatives Revenue (USD Million) by Type: 2015 VS 2019 VS 2025

Table 2. Breakdown of Blood Plasma Derivatives by Company Type (Tier 1, Tier 2 and Tier 3)

Table 3. Global Blood Plasma Derivatives Revenue (USD Million) by Application: 2015 VS 2019 VS 2025

Table 4. Market Opportunities in Next Few Years

Table 5. Market Risks Analysis

Table 6. Market Drivers

Table 7. Grifols Basic Information, Manufacturing Base and Competitors

Table 8. Grifols Blood Plasma Derivatives Major Business

Table 9. Grifols Blood Plasma Derivatives Total Revenue (USD Million) (2017-2018)

Table 10. Grifols SWOT Analysis

Table 11. Grifols Blood Plasma Derivatives Product and Services

Table 12. Grifols Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 13. Octapharma AG Basic Information, Manufacturing Base and Competitors

Table 14. Octapharma AG Blood Plasma Derivatives Major Business

Table 15. Octapharma AG Blood Plasma Derivatives Total Revenue (USD Million) (2017-2018)

Table 16. Octapharma AG SWOT Analysis

Table 17. Octapharma AG Blood Plasma Derivatives Product and Services

Table 18. Octapharma AG Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 19. Biotest AG Basic Information, Manufacturing Base and Competitors

Table 20. Biotest AG Blood Plasma Derivatives Major Business

Table 21. Biotest AG Blood Plasma Derivatives Total Revenue (USD Million) (2017-2018)

Table 22. Biotest AG SWOT Analysis

Table 23. Biotest AG Blood Plasma Derivatives Product and Services

Table 24. Biotest AG Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 25. SK Plasma Basic Information, Manufacturing Base and Competitors

Table 26. SK Plasma Blood Plasma Derivatives Major Business

Table 27. SK Plasma Blood Plasma Derivatives Total Revenue (USD Million) (2017-2018)

Table 28. SK Plasma SWOT Analysis

Table 29. SK Plasma Blood Plasma Derivatives Product and Services

Table 30. SK Plasma Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 31. LFB Basic Information, Manufacturing Base and Competitors

Table 32. LFB Blood Plasma Derivatives Major Business

Table 33. LFB Blood Plasma Derivatives Total Revenue (USD Million) (2017-2018)

Table 34. LFB SWOT Analysis

Table 35. LFB Blood Plasma Derivatives Product and Services

Table 36. LFB Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 37. Fusion Health Care Basic Information, Manufacturing Base and Competitors

Table 38. Fusion Health Care Blood Plasma Derivatives Major Business

Table 39. Fusion Health Care Blood Plasma Derivatives Total Revenue (USD Million) (2017-2018)

Table 40. Fusion Health Care SWOT Analysis

Table 41. Fusion Health Care Blood Plasma Derivatives Product and Services

Table 42. Fusion Health Care Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 43. Takeda Basic Information, Manufacturing Base and Competitors

Table 44. Takeda Blood Plasma Derivatives Major Business

Table 45. Takeda Blood Plasma Derivatives Total Revenue (USD Million) (2017-2018)

Table 46. Takeda SWOT Analysis

Table 47. Takeda Blood Plasma Derivatives Product and Services

Table 48. Takeda Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 49. Baxter International Basic Information, Manufacturing Base and Competitors

Table 50. Baxter International Blood Plasma Derivatives Major Business

Table 51. Baxter International Blood Plasma Derivatives Total Revenue (USD Million) (2017-2018)

Table 52. Baxter International SWOT Analysis

Table 53. Baxter International Blood Plasma Derivatives Product and Services

Table 54. Baxter International Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 55. Green Cross Corporation Basic Information, Manufacturing Base and Competitors

Table 56. Green Cross Corporation Blood Plasma Derivatives Major Business

Table 57. Green Cross Corporation Blood Plasma Derivatives Total Revenue (USD Million) (2017-2018)

Table 58. Green Cross Corporation SWOT Analysis

Table 59. Green Cross Corporation Blood Plasma Derivatives Product and Services

Table 60. Green Cross Corporation Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 61. CSL Limited Basic Information, Manufacturing Base and Competitors

Table 62. CSL Limited Blood Plasma Derivatives Major Business

Table 63. CSL Limited Blood Plasma Derivatives Total Revenue (USD Million) (2017-2018)

Table 64. CSL Limited SWOT Analysis

Table 65. CSL Limited Blood Plasma Derivatives Product and Services

Table 66. CSL Limited Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 67. Hualan Biological Engineering Basic Information, Manufacturing Base and Competitors

Table 68. Hualan Biological Engineering Blood Plasma Derivatives Major Business

Table 69. Hualan Biological Engineering Blood Plasma Derivatives Total Revenue (USD Million) (2017-2018)

Table 70. Hualan Biological Engineering SWOT Analysis

Table 71. Hualan Biological Engineering Blood Plasma Derivatives Product and Services

Table 72. Hualan Biological Engineering Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 73. China Biologic Products Basic Information, Manufacturing Base and Competitors

Table 74. China Biologic Products Blood Plasma Derivatives Major Business

Table 75. China Biologic Products Blood Plasma Derivatives Total Revenue (USD Million) (2017-2018)

Table 76. China Biologic Products SWOT Analysis

Table 77. China Biologic Products Blood Plasma Derivatives Product and Services

Table 78. China Biologic Products Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 79. Bayer AG Basic Information, Manufacturing Base and Competitors

Table 80. Bayer AG Blood Plasma Derivatives Major Business

Table 81. Bayer AG Blood Plasma Derivatives Total Revenue (USD Million) (2017-2018)

Table 82. Bayer AG SWOT Analysis

Table 83. Bayer AG Blood Plasma Derivatives Product and Services

Table 84. Bayer AG Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 85. Kedrion Biopharma Basic Information, Manufacturing Base and Competitors

Table 86. Kedrion Biopharma Blood Plasma Derivatives Major Business

Table 87. Kedrion Biopharma Blood Plasma Derivatives Total Revenue (USD Million) (2017-2018)

Table 88. Kedrion Biopharma SWOT Analysis

Table 89. Kedrion Biopharma Blood Plasma Derivatives Product and Services

Table 90. Kedrion Biopharma Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 91. BDI Pharma Basic Information, Manufacturing Base and Competitors

Table 92. BDI Pharma Blood Plasma Derivatives Major Business

Table 93. BDI Pharma Blood Plasma Derivatives Total Revenue (USD Million) (2017-2018)

Table 94. BDI Pharma SWOT Analysis

Table 95. BDI Pharma Blood Plasma Derivatives Product and Services

Table 96. BDI Pharma Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

Table 97. Global Blood Plasma Derivatives Sales by Manufacturer (2018-2019) (K MT)

Table 98. Global Blood Plasma Derivatives Revenue by Manufacturer (2018-2019) (USD Million)

Table 99. Global Blood Plasma Derivatives Sales by Regions (2015-2020) (K MT)

Table 100. Global Blood Plasma Derivatives Sales Market Share by Regions (2015-2020)

Table 101. Global Blood Plasma Derivatives Revenue by Regions (2015-2020) (USD Million)

Table 102. North America Blood Plasma Derivatives Sales by Countries (2015-2020) (K MT)

Table 103. North America Blood Plasma Derivatives Sales Market Share by Countries (2015-2020)

Table 104. North America Blood Plasma Derivatives Revenue by Countries (2015-2020) (USD Million)

Table 105. North America Blood Plasma Derivatives Revenue Market Share by Countries (2015-2020)

Table 106. Europe Blood Plasma Derivatives Sales by Countries (2015-2020) (K MT)

Table 107. Europe Blood Plasma Derivatives Sales Market Share by Countries (2015-2020)

Table 108. Europe Blood Plasma Derivatives Revenue by Countries (2015-2020) (USD Million)

Table 109. Asia-Pacific Blood Plasma Derivatives Sales by Regions (2015-2020) (K MT)

Table 110. Asia-Pacific Blood Plasma Derivatives Sales Market Share by Regions (2015-2020)

Table 111. Asia-Pacific Blood Plasma Derivatives Revenue by Regions (2015-2020) (USD Million)

Table 112. South America Blood Plasma Derivatives Sales by Countries (2015-2020) (K MT)

Table 113. South America Blood Plasma Derivatives Sales Market Share by Countries (2015-2020)

Table 114. South America Blood Plasma Derivatives Revenue by Countries (2015-2020) (USD Million)

Table 115. South America Blood Plasma Derivatives Revenue Market Share by Countries (2015-2020)

Table 116. Middle East & Africa Blood Plasma Derivatives Sales by Countries (2015-2020) (K MT)

Table 117. Middle East & Africa Blood Plasma Derivatives Sales Market Share by Countries (2015-2020)

Table 118. Middle East & Africa Blood Plasma Derivatives Revenue by Countries (2015-2020) (USD Million)

Table 119. Middle East & Africa Blood Plasma Derivatives Revenue Market Share by Countries (2015-2020)

Table 120. Global Blood Plasma Derivatives Sales by Type (2015-2020) (K MT)

Table 121. Global Blood Plasma Derivatives Sales Share by Type (2015-2020)

Table 122. Global Blood Plasma Derivatives Revenue by Type (2015-2020) (USD Million)

Table 123. Global Blood Plasma Derivatives Revenue Share by Type (2015-2020)

Table 124. Global Blood Plasma Derivatives Sales by Application (2015-2020) (K MT)

Table 125. Global Blood Plasma Derivatives Sales Share by Application (2015-2020)

Table 126. Global Blood Plasma Derivatives Sales Forecast by Regions (2021-2025) (K MT)

Table 127. Global Blood Plasma Derivatives Market Share Forecast by Regions (2021-2025)

Table 128. Global Blood Plasma Derivatives Sales Forecast by Type (2021-2025) (K MT)

Table 129. Global Blood Plasma Derivatives Market Share Forecast by Type (2021-2025)

Table 130. Global Blood Plasma Derivatives Sales Forecast by Application (2021-2025)

Table 131. Global Blood Plasma Derivatives Market Share Forecast by Application (2021-2025)

Table 132. Direct Channel Pros & Cons

Table 133. Indirect Channel Pros & Cons

Table 134. Distributors/Traders/ Dealers List

List of Figures

Figure 1. Blood Plasma Derivatives Picture

Figure 2. Global Sales Market Share of Blood Plasma Derivatives by Type in 2019

Figure 3. Albumin Picture

Figure 4. Factor VIII Picture

Figure 5. Factor IX Picture

Figure 6. Immunoglobulin Picture

Figure 7. Hyperimmune Globulin Picture

Figure 8. Others Picture

Figure 9. Blood Plasma Derivatives Sales Market Share by Application in 2018

Figure 10. Hospitals Picture

Figure 11. Clinics Picture

Figure 12. Other End Users Picture

Figure 13. Global Blood Plasma Derivatives Market Status and Outlook (2015-2025) (USD Million)

Figure 14. United States Blood Plasma Derivatives Revenue (Value) and Growth Rate (2015-2025)

Figure 15. Canada Blood Plasma Derivatives Revenue (Value) and Growth Rate (2015-2025)

Figure 16. Mexico Blood Plasma Derivatives Revenue (Value) and Growth Rate (2015-2025)

Figure 17. Germany Blood Plasma Derivatives Revenue (Value) and Growth Rate (2015-2025)

Figure 18. France Blood Plasma Derivatives Revenue (Value) and Growth Rate (2015-2025)

Figure 19. UK Blood Plasma Derivatives Revenue (Value) and Growth Rate (2015-2025)

Figure 20. Russia Blood Plasma Derivatives Revenue (Value) and Growth Rate (2015-2025)

Figure 21. Italy Blood Plasma Derivatives Revenue (Value) and Growth Rate (2015-2025)

Figure 22. China Blood Plasma Derivatives Revenue (Value) and Growth Rate (2015-2025)

Figure 23. Japan Blood Plasma Derivatives Revenue (Value) and Growth Rate (2015-2025)

Figure 24. Korea Blood Plasma Derivatives Revenue (Value) and Growth Rate (2015-2025)

Figure 25. India Blood Plasma Derivatives Revenue (Value) and Growth Rate (2015-2025)

Figure 26. Southeast Asia Blood Plasma Derivatives Revenue (Value) and Growth Rate (2015-2025)

Figure 27. Australia Blood Plasma Derivatives Revenue (Value) and Growth Rate (2015-2025) (USD Million)

Figure 28. Brazil Blood Plasma Derivatives Revenue (Value) and Growth Rate (2015-2025)

Figure 29. Egypt Blood Plasma Derivatives Revenue (Value) and Growth Rate (2015-2025)

Figure 30. Saudi Arabia Blood Plasma Derivatives Revenue (Value) and Growth Rate (2015-2025)

Figure 31. South Africa Blood Plasma Derivatives Revenue (Value) and Growth Rate (2015-2025)

Figure 32. Turkey Blood Plasma Derivatives Revenue (Value) and Growth Rate (2015-2025)

Figure 33. Global Blood Plasma Derivatives Sales Market Share by Manufacturer in 2019

Figure 34. Global Blood Plasma Derivatives Revenue Market Share by Manufacturer in 2019

Figure 35. Top 3 Blood Plasma Derivatives Manufacturer (Revenue) Market Share in 2019

Figure 36. Top 6 Blood Plasma Derivatives Manufacturer (Revenue) Market Share in 2019

Figure 37. Key Manufacturer Market Share Trend

Figure 38. Global Blood Plasma Derivatives Sales and Growth Rate (2015-2020) (K MT)

Figure 39. Global Blood Plasma Derivatives Revenue and Growth Rate (2015-2020) (USD Million)

Figure 40. Global Blood Plasma Derivatives Revenue Market Share by Regions (2015-2020)

Figure 41. Global Blood Plasma Derivatives Revenue Market Share by Regions in 2018

Figure 42. North America Blood Plasma Derivatives Sales and Growth Rate (2015-2020)

Figure 43. Europe Blood Plasma Derivatives Sales and Growth Rate (2015-2020)

Figure 44. Asia-Pacific Blood Plasma Derivatives Sales and Growth Rate (2015-2020)

Figure 45. South America Blood Plasma Derivatives Sales and Growth Rate (2015-2020)

Figure 46. Middle East & Africa Blood Plasma Derivatives Sales and Growth Rate (2015-2020)

Figure 47. North America Blood Plasma Derivatives Revenue and Growth Rate (2015-2020) (USD Million)

Figure 48. North America Blood Plasma Derivatives Sales Market Share by Countries (2015-2020)

Figure 49. North America Blood Plasma Derivatives Sales Market Share by Countries in 2018

Figure 50. North America Blood Plasma Derivatives Revenue Market Share by Countries (2015-2020) (USD Million)

Figure 51. North America Blood Plasma Derivatives Revenue Market Share by Countries in 2018

Figure 52. United States Blood Plasma Derivatives Sales and Growth Rate (2015-2020) (K MT)

Figure 53. Canada Blood Plasma Derivatives Sales and Growth Rate (2015-2020) (K MT)

Figure 54. Mexico Blood Plasma Derivatives Sales and Growth Rate (2015-2020) (K MT)

Figure 55. Europe Blood Plasma Derivatives Revenue and Growth Rate (2015-2020) (USD Million)

Figure 56. Europe Blood Plasma Derivatives Revenue Market Share by Countries (2015-2020)

Figure 57. Europe Blood Plasma Derivatives Revenue Market Share by Countries in 2019

Figure 58. Germany Blood Plasma Derivatives Sales and Growth Rate (2015-2020) (K MT)

Figure 59. UK Blood Plasma Derivatives Sales and Growth Rate (2015-2020) (K MT)

Figure 60. France Blood Plasma Derivatives Sales and Growth Rate (2015-2020) (K MT)

Figure 61. Russia Blood Plasma Derivatives Sales and Growth Rate (2015-2020) (K MT)

Figure 62. Italy Blood Plasma Derivatives Sales and Growth Rate (2015-2020) (K MT)

Figure 63. Asia-Pacific Blood Plasma Derivatives Revenue and Growth Rate (2015-2020) (USD Million)

Figure 64. Asia-Pacific Blood Plasma Derivatives Sales Market Share by Regions 2019

Figure 65. Asia-Pacific Blood Plasma Derivatives Revenue Market Share by Regions 2019

Figure 66. China Blood Plasma Derivatives Sales and Growth Rate (2015-2020) (K MT)

Figure 67. Japan Blood Plasma Derivatives Sales and Growth Rate (2015-2020) (K MT)

Figure 68. Korea Blood Plasma Derivatives Sales and Growth Rate (2015-2020) (K MT)

Figure 69. India Blood Plasma Derivatives Sales and Growth Rate (2015-2020) (K MT)

Figure 70. Southeast Asia Blood Plasma Derivatives Sales and Growth Rate (2015-2020) (K MT)

Figure 71. South America Blood Plasma Derivatives Revenue and Growth Rate (2015-2020) (USD Million)

Figure 72. South America Blood Plasma Derivatives Sales Market Share by Countries in 2019

Figure 73. South America Blood Plasma Derivatives Revenue Market Share by Countries in 2019

Figure 74. Brazil Blood Plasma Derivatives Sales and Growth Rate (2015-2020) (K MT)

Figure 75. Argentina Blood Plasma Derivatives Sales and Growth Rate (2015-2020) (K MT)

Figure 76. Middle East and Africa Blood Plasma Derivatives Revenue and Growth Rate (2015-2020) (USD Million)

Figure 77. Middle East and Africa Blood Plasma Derivatives Sales Market Share by Countries in 2019

Figure 78. Middle East and Africa Blood Plasma Derivatives Revenue Market Share by Countries (2015-2020)

Figure 79. Middle East and Africa Blood Plasma Derivatives Revenue Market Share by Countries in 2019

Figure 80. Saudi Arabia Blood Plasma Derivatives Sales and Growth Rate (2015-2020) (K MT)

Figure 81. Egypt Blood Plasma Derivatives Sales and Growth Rate (2015-2020) (K MT)

Figure 82. Turkey Blood Plasma Derivatives Sales and Growth Rate (2015-2020) (K MT)

Figure 83. South Africa Blood Plasma Derivatives Sales and Growth Rate (2015-2020) (K MT)

Figure 84. Global Blood Plasma Derivatives Sales and Growth Rate (2021-2025) (K MT)

Figure 85. Global Blood Plasma Derivatives Revenue and Growth Rate (2021-2025) (USD Million)

Figure 86. North America Sales Blood Plasma Derivatives Market Forecast (2021-2025) (K MT)

Figure 87. Europe Sales Blood Plasma Derivatives Market Forecast (2021-2025) (K MT)

Figure 88. Asia-Pacific Sales Blood Plasma Derivatives Market Forecast (2021-2025) (K MT)

Figure 89. South America Sales Blood Plasma Derivatives Market Forecast (2021-2025) (K MT)

Figure 90. Middle East & Africa Sales Blood Plasma Derivatives Market Forecast (2021-2025) (K MT)

Figure 91. Sales Channel: Direct Channel vs Indirect Channel